IP Library Granted Patent US 11,554,119
Granted Patent B2
US 11,554,119 · App. 16/665,841 · Granted Jan 17, 2023

Composition having improved flowabilty and methods for making and using the composition

Inventors: Ian John Wilkinson (Teaneck, NJ); Charles Hollett Fahrenholz (Teaneck, NJ)
Assignee: Phibro Animal Health Corporation
A61K31/505A23K10/30A23K20/137A61K9/1611A61K36/899A61K47/44A61P1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,554,119
App. No.
16/665,841
Granted
Jan 17, 2023
Kind
B2
Abstract

Disclosed compositions comprise a therapeutic agent and a carrier selected, or processed to have, an acceptable composite flow index, a granular particle size of 18 mesh to 80 mesh, or both, such as processed granular wheat middlings. The composition may also comprise an oil and/or micro tracers. Suitable granular wheat middlings may have a size range of from 18 mesh to 80 mesh, such as 20 mesh to 80 mesh. The composition has improved flowability characteristics, compared to a composition where the carrier, such as processed wheat middlings, are powdered and/or flakey. Certain embodiments concern a composition comprising, consisting essentially of, or consisting of, nicarbazin, granular wheat middlings, soybean oil and micro tracers. The composition may be administered to an animal, for example, to treat or prevent coccidiosis. Also disclosed herein are methods for making and using the composition.

Claims (23)

1. A composition, comprising:

granular wheat middlings having a size of from 20 mesh to 80 mesh;

soybean oil;

nicarbazin; and

micro tracers.

2. The composition according to claim 1 , comprising from 2 wt % to 4 wt % soybean oil, from 10 wt % to 30 wt % nicarbazin, from greater than zero to 1 wt % micro tracers, and from 65 wt % to 88 wt % wheat middlings.

3. The composition according to claim 1 , wherein the granular wheat middlings have:

an angle of repose of from greater than zero to 40;

a percent compressibility of from zero to 20%;

a critical orifice diameter of from greater than zero to 15;

a composite flow index of from greater than 45 to 100; or

a combination thereof.

4. The composition according to claim 3 , wherein the granular wheat middlings have an angle of repose of from 30 to 40, a percent compressibility of from 15% to 20%, a critical orifice diameter of from 3 to 8, and a composite flow index of from 70 to 85.

5. The composition according to claim 1 , wherein the composition has:

an angle of repose of from greater than zero to 40;

a percent compressibility of from zero to 20%;

a critical orifice diameter of from greater than zero to 30;

a composite flow index of from greater than 45 to 100; or

a combination thereof.

6. The composition according to claim 5 , wherein the composition has an angle of repose of from 30 to 40, a percent compressibility of from 10% to 20%, a critical orifice diameter of from 20 to 30, and a composite flow index of from 55 to 60.

7. The composition according to claim 6 , wherein the composition has a composite flow index from 30% to 200% greater than a comparable composition comprising powdered and/or flaky wheat middlings.

8. The composition according to claim 1 , further comprising a feed, a feed supplement, or a combination thereof.

9. The composition according to claim 8 , wherein the feed supplement comprises yucca, quillaja , silica, mineral clay, glucan, mannans, or a combination thereof.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS AT REEL 056139, FRAME 0578 Recorded Jul 17, 2024
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC
Reel/Frame 068404/0557 →
SECURITY INTEREST Recorded Jul 15, 2024
From: PHIBRO ANIMAL HEALTH CORPORATION; PRINCE AGRI PRODUCTS, INC.; OMNIGEN RESEARCH, LLC
To: COÖPERATIEVE RABOBANK U.A., NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 068370/0043 →
SECURITY INTEREST Recorded May 5, 2021
From: PHIBRO ANIMAL HEALTH CORPORATION; OMNIGEN RESEARCH, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 056139/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2020
From: WILKINSON, IAN; FAHRENHOLZ, CHARLES H.
To: PHIBRO ANIMAL HEALTH CORPORATION
Reel/Frame 053050/0744 →